CSL Behring

Tweet this page
<
2020
2021
2022
2023
2024
>
Registration as it was on 21 May 2021
How to read and use this data card.
Download this datacard
The following entries are flagged as duplicates of this organisation: 322536115782-29

Overview

Lobbying Costs

75,000€

Financial year: Jul 2019 - Jun 2020

Lobbyists (Full time equivalent)

1.25 Fte (3)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    CSL Behring

    EU Transparency Register

    030031840349-92 First registered on 17 Nov 2020

    Goals / Remit

    CSL Behring has been at the forefront of biotherapeutics research and development for more than 100 years. We trace our roots to Emil von Behring, the first Nobel Prize recipient in physiology and medicine.
    Throughout the years our passion and commitment to delivering on our promise to save and improve the lives of people with rare and serious diseases has remained strong.
    Today, we are one of the largest and fastest growing protein biotherapeutics businesses in the world with more than 16,000 employees operating in more than 30 countries. Our products are delivered to patients in more than 60 countries. We offer the broadest range of quality plasma-derived and recombinant therapies in the protein biotherapeutics industry, and have substantial markets in North America, Europe, Asia and Australia.

    Main EU files targeted

    Pharmaceutical Strategy (including OMP legislation)
    EU blood and tissues and cells legislation
    Industrial Strategy
    European Health Union
    Trade Strategy
    Horizon 2020

    Address

    Head Office
    1020 First Avenue
    King of Prussia PA 19406-0901 USA
    UNITED STATES
    EU Office
    Bedrijvenlaan 11
    Mechelen B-2800
    BELGIUM
  • People

    Total lobbyists declared

    3

    Employment timeLobbyists
    50%2
    25%1

    Lobbyists (Full time equivalent)

    1.25

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    0 accreditations were / are live (in bold) for the selected state of 21 May 2021

    Name Start date End Date
    Ruediger Gatermann 06 Nov 2024 05 Nov 2025
    irene de Cara Torres 25 Oct 2024 24 Oct 2025
    Ms Joelle Khraiche 23 Mar 2024 26 Apr 2024
    Mr Ruediger Gatermann 03 Feb 2024 26 Apr 2024
    Ms Joelle Khraiche 16 Mar 2023 16 Mar 2024
    Ms Irene de Cara Torres 14 Mar 2023 14 Mar 2024
    Mr Ruediger Gatermann 18 Feb 2023 03 Feb 2024
    Ms Irene de Cara Torres 15 Mar 2022 14 Mar 2023
    Ms Joelle Khraiche 04 Mar 2022 04 Mar 2023
    Mr Ruediger Gatermann 01 Mar 2022 18 Feb 2023

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    II - In-house lobbyists and trade/business/professional associations

    Subcategory

    Companies & groups

  • Networking

    Affiliation

    PPTA - The Plasma Protein Therapeutics Association
    Eucope - The European Confederation of Pharmaceutical Entrepreneurs
    ARM - The Alliance for Regenerative Medicine
    Europabio - The European Association for Bioindustries

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jul 2019 - Jun 2020

    Lobbying costs for closed financial year

    75,000€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    None

    Other activities

    None declared

  • Meetings

    Meetings

    None declared

Download this datacard